Literature DB >> 34515963

Successful treatment with denosumab for two cases with hypercalcemia due to vitamin D intoxication and associated acute kidney injury.

Katharina Barth1, Michal Sedivy2, Gregor Lindner3, Christoph Schwarz4.   

Abstract

Hypervitaminosis D is a rare reason for hypercalcemia and associated with acute kidney injury. We report on two cases of hypercalcemia and acute kidney injury because of vitamin D intoxication successfully treated with denosumab. Case 1 is an 83-year-old woman, who was initially treated for 2 weeks with intravenous hydration, steroids and thereafter with furosemide without any effect on serum calcium levels and renal function. Because acute renal failure discouraged us to use intravenous bisphosphonate therapy, we applicated 60 mg denusomab subcutaneously. This led to a prompt reduction in serum calcium levels and improvement of renal function within 1 week. Case 2 is a 45-year-old athletic woman, who refused the standard therapy of steroids and forced diuresis for vitamin D intoxication. After 1 day of rehydration therapy, she received 60 mg denusomab. Similar to case 1 serum calcium declined and renal function improved within 7 days.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  Acute kidney injury; Denosumab; Hypercalcemia; Hypervitaminosis D

Mesh:

Substances:

Year:  2021        PMID: 34515963      PMCID: PMC8810995          DOI: 10.1007/s13730-021-00643-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  14 in total

1.  Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study.

Authors:  Daniel V Dudenkov; Barbara P Yawn; Sara S Oberhelman; Philip R Fischer; Ravinder J Singh; Stephen S Cha; Julie A Maxson; Stephanie M Quigg; Tom D Thacher
Journal:  Mayo Clin Proc       Date:  2015-05       Impact factor: 7.616

2.  Mutations in CYP24A1 and idiopathic infantile hypercalcemia.

Authors:  Karl P Schlingmann; Martin Kaufmann; Stefanie Weber; Andrew Irwin; Caroline Goos; Ulrike John; Joachim Misselwitz; Günter Klaus; Eberhard Kuwertz-Bröking; Henry Fehrenbach; Anne M Wingen; Tülay Güran; Joost G Hoenderop; René J Bindels; David E Prosser; Glenville Jones; Martin Konrad
Journal:  N Engl J Med       Date:  2011-06-15       Impact factor: 91.245

Review 3.  Clinical review: Rare causes of hypercalcemia.

Authors:  Thomas P Jacobs; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2005-08-30       Impact factor: 5.958

4.  Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States.

Authors:  Takako Araki; Michael F Holick; Bianca D Alfonso; Esti Charlap; Carla M Romero; Dahlia Rizk; Lisa G Newman
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

5.  1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D.

Authors:  Hector F Deluca; Jean M Prahl; Lori A Plum
Journal:  Arch Biochem Biophys       Date:  2010-10-18       Impact factor: 4.013

6.  The other side of vitamin D therapy: 
a case series of acute kidney injury due to malpractice-related vitamin D intoxication
.

Authors:  Muzafar Wani; Imtiaz Wani; Khurshid Banday; Mohd Ashraf
Journal:  Clin Nephrol       Date:  2016-11       Impact factor: 0.975

Review 7.  Denosumab: a new agent in the management of hypercalcemia of malignancy.

Authors:  Sonali Thosani; Mimi I Hu
Journal:  Future Oncol       Date:  2015-09-25       Impact factor: 3.404

8.  Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats.

Authors:  Jing Sun; Bao Sun; Wei Wang; Xiuchun Han; Hongrui Liu; Juan Du; Wei Feng; Bo Liu; Norio Amizuka; Minqi Li
Journal:  J Mol Histol       Date:  2016-06-02       Impact factor: 2.611

9.  Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction.

Authors:  Shannon Palmer; Frank Tillman; Preetika Sharma; Jessica Auten; Kathryn Owen; Stephen M Clark; Katherine P Morgan
Journal:  Ann Pharmacother       Date:  2020-08-27       Impact factor: 3.154

10.  Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients.

Authors:  Cyril Mousseaux; Axelle Dupont; Cédric Rafat; Kenneth Ekpe; Etienne Ghrenassia; Lionel Kerhuel; Fanny Ardisson; Eric Mariotte; Virginie Lemiale; Benoît Schlemmer; Elie Azoulay; Lara Zafrani
Journal:  Ann Intensive Care       Date:  2019-11-27       Impact factor: 6.925

View more
  1 in total

Review 1.  Renal sarcoidosis.

Authors:  Marta Calatroni; Gabriella Moroni; Francesco Reggiani; Claudio Ponticelli
Journal:  J Nephrol       Date:  2022-06-27       Impact factor: 4.393

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.